Regxia is a unique scientific and regulatory consulting firm servicing the pharmaceutical and biotech industries. With a primary focus on small and midsized customers, we provide knowledge, experience and innovation to lead your clinical and marketing applications through to FDA and Health Canada approval.
Regxia – Celebrating 10 years of being your partner throughout all phases of development and marketing.
1C – 64 Jardin Drive
Vaughan, ON L4K 3P3
Patent Drug/New Drug/Brand Name Drugs
|Professional Responsibility (Regulatory Process):
eCTD - ePublishing
Good Clinical Practice (GCP)
Biological License Approval (BLA)
Investigational New Drug (IND)
New Drug Approval (NDA)
Premarket Approval (PMA)
Premarket Notification (510k)